Selected article for: "clinical severity and high proportion"

Author: Cevey-Macherel, Manon; Galetto-Lacour, Annick; Gervaix, Alain; Siegrist, Claire-Anne; Bille, Jacques; Bescher-Ninet, Béatrice; Kaiser, Laurent; Krahenbuhl, Jean-Daniel; Gehri, Mario
Title: Etiology of community-acquired pneumonia in hospitalized children based on WHO clinical guidelines
  • Cord-id: e2pgjynr
  • Document date: 2009_2_24
  • ID: e2pgjynr
    Snippet: Community-acquired pneumonia (CAP) is a major cause of death in developing countries and of morbidity in developed countries. The objective of the study was to define the causative agents among children hospitalized for CAP defined by WHO guidelines and to correlate etiology with clinical severity and surrogate markers. Investigations included an extensive etiological workup. A potential causative agent was detected in 86% of the 99 enrolled patients, with evidence of bacterial (53%), viral (67%
    Document: Community-acquired pneumonia (CAP) is a major cause of death in developing countries and of morbidity in developed countries. The objective of the study was to define the causative agents among children hospitalized for CAP defined by WHO guidelines and to correlate etiology with clinical severity and surrogate markers. Investigations included an extensive etiological workup. A potential causative agent was detected in 86% of the 99 enrolled patients, with evidence of bacterial (53%), viral (67%), and mixed (33%) infections. Streptococcus pneumoniae was accounted for in 46% of CAP. Dehydration was the only clinical sign associated with bacterial pneumonia. CRP and PCT were significantly higher in bacterial infections. Increasing the number of diagnostic tests identifies potential causes of CAP in up to 86% of children, indicating a high prevalence of viruses and frequent co-infections. The high proportion of pneumococcal infections re-emphasizes the importance of pneumococcal immunization.

    Search related documents:
    Co phrase search for related documents
    • absence presence and acute infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • absence presence and acute phase: 1, 2, 3, 4, 5, 6, 7, 8
    • absence presence and low respiratory: 1
    • absence presence and lysis buffer: 1, 2, 3, 4, 5
    • acute infection and adenovirus rsv: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute infection and admission month: 1, 2, 3, 4, 5, 6
    • acute infection and low respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute infection and low respiratory tract infection: 1, 2
    • acute infection and lysis buffer: 1
    • acute phase and admission month: 1, 2
    • acute phase and low respiratory: 1
    • adenovirus rsv and low respiratory: 1, 2, 3, 4, 5, 6
    • adenovirus rsv and low respiratory tract infection: 1
    • adenovirus rsv and lysis buffer: 1